Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 96Gastrointestinal 93Genitourinary 84Thoracic 54Head & Neck 43Other hematologic neoplasm 39Tumor-Agnostic 32Gynecologic 31Lymphoid 23CNS 22Other solid neoplasm 17Plasma cell 15Dermatologic 14Sarcoma 10Other 10Myeloid 6Endocrine 5Classical hematology 2Other neoplasm 1NET 1

Conditions

Hematopoietic and Lymphoid System Neoplasm 1

Interventions

Cyclophosphamide 13Biopsy 13fludarabine phosphate 9Whole-Body Irradiation 9Surveys and Questionnaires 9Peripheral Blood Stem Cell Transplantation 9Busulfan 9Polymerase Chain Reaction 7Mycophenolic Acid 7Early Intervention, Educational 7Tacrolimus 6Gene Expression Profiling 6Educational Status 6Colposcopy 6Carboplatin 6fludarabine 5Paclitaxel 5Microarray Analysis 5Methotrexate 5Methods 5Melphalan 5Immunohistochemistry 5Epoetin Alfa 5Decitabine 5Cyclosporine 5Cisplatin 5Celecoxib 5Antilymphocyte Serum 5Aminolevulinic Acid 5Sulindac 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Standard of Care × Other neoplasm × Clear all
NCT05772130 2026-01-05

Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study

City of Hope Medical Center

Phase NA Recruiting
240 enrolled
Other neoplasmOther solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡